|
|
||||||||
1From the Cell and Molecular Unit, School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom; the 2Cardiff Institute of Tissue Engineering and Repair, Cardiff University, Cardiff, United Kingdom; and 3Cambridge Antibody Technology, Cambridge, United Kingdom.
PURPOSE. Inhibition of TGF-ß reduces myofibroblast differentiation and fibrosis in the cornea. Determining the actions of distinct TGF-ß isoforms and their inhibitors during early corneal wound healing is an essential step in guiding therapeutic intervention.
METHODS. Bovine serum-free corneal cell and wounded organ cultures were challenged with a range of concentrations of TGF-ß1, -ß2, and -ß3; IL-10; and neutralizing human monoclonal antibodies (mAbs) against TGF-ß1 (CAT-192) or -ß2, (CAT-152). Cultures were assessed for re-epithelialization, proliferation (cell counts and cresyl violet assay), morphology (histologic examination), repopulation of the area under the wound, and myofibroblast transformation (
-smooth muscle actin) between 0 and 5 days.
RESULTS. TGF-ß1 delayed re-epithelialization, increased repopulation of the stroma, increased keratocyte proliferation and was the only isoform to promote myofibroblast differentiation. The anti-TGF-ß1 mAb, CAT-192 promoted re-epithelialization and reduced repopulation of the stroma. Exogenous TGF-ß3 had little effect on re-epithelialization but reduced repopulation of the stroma. IL-10 promoted corneal re-epithelialization at low doses but inhibited this response at high doses. Stromal repopulation was prevented by all doses of IL-10. TGF-ß2 or the anti-TGF-ß2 mAb, CAT-152 had little effect on any repair parameter.
CONCLUSIONS. The results confirm TGF-ß1 as the principal isoform in corneal wound healing and suggest that inhibition of the action of TGF-ß1 can promote corneal wound healing. Treatment with the anti-TGF-ß1 mAb CAT-192 accelerates corneal re-epithelialization but reduces cell repopulation of the stroma. The cytokines TGF-ß3 and IL-10 have opposing actions to that of TGF-ß1.
This article has been cited by other articles:
![]() |
A. M. Bernstein, S. S. Twining, D. J. Warejcka, E. Tall, and S. K. Masur Urokinase Receptor Cleavage: A Crucial Step in Fibroblast-to-Myofibroblast Differentiation Mol. Biol. Cell, July 1, 2007; 18(7): 2716 - 2727. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |